Cannabis Legalisation in the UK: Why the Debate Has Reached a Tipping Point in 2025

The debate over cannabis legalisation in the UK has reached a tipping point. For the first time, a majority of the public supports legalisation, with 53% in favour according to November 2024 YouGov polling, up from just 24% in 2014. Support is even higher among younger voters: 68% of 18-24 year olds back legalisation, as do 61% of 25-49 year olds. Cross-party MPs, police chiefs, medical professionals, and economists have called for evidence-based reform, pointing to the failure of prohibition and the success of regulated legal markets in Canada, Germany, and 24 US states.

Yet the UK government remains firmly opposed. The Labour government, elected in July 2024, has ruled out legalisation, with Home Secretary Yvette Cooper stating in September 2024: "We will not legalise cannabis. It is harmful, particularly to young people, and legalisation would send the wrong message." This position is increasingly isolated internationally and out of step with public opinion, scientific evidence, and the experience of countries that have legalised.

The question is no longer if the UK will legalise cannabis, but when and how. This article examines the case for and against legalisation, the international evidence, and the political obstacles to reform.

The current law: prohibition and its consequences

Cannabis is a Class B drug under the Misuse of Drugs Act 1971. Possession carries a maximum penalty of five years in prison and an unlimited fine, though most first-time offenders receive a warning or caution. Supply carries a maximum penalty of 14 years in prison.

In practice, enforcement is inconsistent. Some police forces have de facto decriminalised small-scale possession, issuing warnings rather than arrests. Others continue to arrest and charge users. In 2023, there were 133,000 cannabis possession offences recorded in England and Wales, down from 200,000 in 2010, but still a significant burden on police and courts.

The consequences of prohibition are severe:

A £2.6 billion criminal market

The UK cannabis market is worth an estimated £2.6 billion annually, according to the Institute for Economic Affairs. This entire market is controlled by criminal gangs, generating no tax revenue and funding other criminal activity including violence, exploitation, and people trafficking.

Cannabis production in the UK has industrialised, with Vietnamese organised crime groups running large-scale indoor farms in residential properties. These operations often involve modern slavery, with trafficked Vietnamese nationals forced to tend the plants under threat of violence. In 2023, police raided 5,200 cannabis farms in England and Wales, but this is estimated to be only 10-15% of the total.

Criminalisation of users

133,000 people were criminalised for cannabis possession in 2023, the majority young men from deprived backgrounds. A cannabis conviction can result in:

• A criminal record that affects employment, education, and travel
• Fines that push people into debt
• Prison for repeat offenders or larger quantities

The Lammy Review (2017) found that Black people are nine times more likely to be stopped and searched for drugs than white people, despite similar usage rates. Cannabis prohibition disproportionately harms minority communities.

Barriers to medical use

Medical cannabis has been legal in the UK since November 2018, following high-profile campaigns by families of children with severe epilepsy. However, access remains severely restricted. As of 2024:

• Fewer than 5,000 NHS prescriptions have been issued, mostly for rare epilepsy conditions
• Private prescriptions cost £150-300 per month, unaffordable for most patients
• NICE guidelines recommend cannabis-based medicines for only a handful of conditions, despite evidence for chronic pain, PTSD, and other conditions

Thousands of patients who could benefit from medical cannabis are forced to choose between suffering, paying exorbitant private fees, or buying from the illegal market.

The case for legalisation

Advocates for legalisation argue that prohibition has failed to reduce use, criminalises millions, and enriches criminals. A regulated legal market would:

1. Reduce crime and criminal justice costs

Legalisation would eliminate the illegal cannabis market (or at least drastically reduce it), cutting off a major revenue stream for organised crime. It would also free up police, court, and prison resources currently spent on cannabis offences.

The Institute for Economic Affairs estimates that legalisation would save £300-500 million annually in criminal justice costs, including:

• Policing costs of investigating, arresting, and processing cannabis offences
• Court costs of prosecuting possession and supply cases
• Prison costs of incarcerating cannabis offenders (around 1,000 people are in prison for cannabis offences at any time)

2. Generate tax revenue

A legal, regulated cannabis market could generate £500-800 million per year in tax revenue, according to the Institute for Economic Affairs. This assumes:

• £2.6 billion annual market (current estimated size)
• 20-30% tax rate (similar to Canada and US states)
• Some reduction in market size due to higher legal prices (though this could be offset by increased use among adults who currently abstain due to illegality)

For comparison:

• Canada generated CAD $4.3 billion (£2.5 billion) in cannabis tax revenue from 2018-2023
• California generated $5.3 billion (£4.2 billion) from 2018-2023
• Colorado generated $2.1 billion (£1.6 billion) from 2014-2023

Tax revenue could be ring-fenced for public health campaigns, addiction treatment, and education, as in Canada and several US states.

3. Improve public health

A regulated legal market would allow for:

• Quality control — testing for contaminants, pesticides, and potency
• Age restrictions — legal retailers check ID; illegal dealers do not
• Public health messaging — packaging can include health warnings and information on safer use
• Separation from harder drugs — legal cannabis users would not be exposed to dealers selling heroin, cocaine, or other drugs

Currently, the illegal market has no quality control. Cannabis is often contaminated with glass, sand, or synthetic cannabinoids to increase weight or potency. High-potency "skunk" strains (20-30% THC) dominate the market, increasing the risk of cannabis use disorder and psychosis, particularly among young users.

A legal market could offer lower-potency products and CBD-rich strains that are less harmful, along with public health campaigns on safer use.

4. Expand medical access

Legalisation would make it easier for patients to access cannabis for medical conditions. In Canada and US states that have legalised, medical cannabis is widely available for conditions including:

• Chronic pain
• PTSD
• Anxiety and depression
• Epilepsy
• Multiple sclerosis
• Cancer-related symptoms (nausea, appetite loss, pain)

While the evidence base is still developing, many patients report significant benefits, and medical cannabis is far safer than opioids for chronic pain.

5. Racial justice

Cannabis prohibition disproportionately harms Black and minority ethnic communities. Legalisation would end the criminalisation of hundreds of thousands of people, mostly young men from deprived backgrounds, and reduce racial disparities in stop-and-search and arrests.

In US states that have legalised, cannabis arrests have fallen by 90-95%, and some states have expunged past cannabis convictions, removing barriers to employment and education for hundreds of thousands of people.

The case against legalisation

Opponents of legalisation, including the UK government, argue that:

1. Cannabis is harmful, especially to young people

Cannabis is not harmless. Regular use, particularly of high-potency strains, is associated with:

• Cannabis use disorder (addiction) in around 9% of users
• Psychosis and schizophrenia, particularly in young people with genetic vulnerability
• Cognitive impairment, especially if use begins in adolescence
• Respiratory problems from smoking
• Impaired driving

The Royal College of Psychiatrists has warned that legalisation could increase use and harm, particularly among young people.

However, prohibition has not prevented these harms. Cannabis use in the UK is higher than in many countries with more liberal policies. Around 7.6% of UK adults used cannabis in the past year (2023 data), similar to Canada (17%) and higher than the Netherlands (5.4%).

2. Legalisation would increase use

Critics argue that legalisation would normalise cannabis and increase use, particularly among young people.

The evidence is mixed:

• In Canada, adult use increased slightly after legalisation (from 14% to 17%), but youth use (ages 15-17) declined from 20% to 10% between 2018 and 2023
• In US states that legalised, youth use either stayed stable or declined, likely because legal retailers check ID and illegal dealers do not
• However, heavy use and cannabis use disorder increased among adults in some jurisdictions

The key is how legalisation is implemented. A well-regulated market with age restrictions, public health campaigns, and limits on advertising can minimise increases in use and harm.

3. Legalisation would send the wrong message

The government argues that legalisation would "send the wrong message" that cannabis is safe.

This argument is weak. Alcohol and tobacco are legal despite being far more harmful than cannabis (alcohol causes 20,000 deaths per year in the UK; tobacco causes 78,000). Legalisation does not mean endorsement—it means regulation and control rather than leaving the market to criminals.

4. The illegal market would persist

Critics argue that a legal market would not eliminate the illegal market, as seen in California, where illegal sales still account for around 50% of the market due to high taxes and regulatory barriers.

This is a valid concern, but it depends on how legalisation is implemented. In Canada, the illegal market has shrunk to around 20-30% of total sales, and continues to decline as legal prices fall and availability increases. The key is to keep taxes low enough that legal cannabis can compete with illegal prices, and to make legal access convenient through retail stores and online sales.

The international evidence

The UK is increasingly isolated in its opposition to cannabis legalisation. Countries and jurisdictions that have legalised include:

Canada (2018)

Canada legalised recreational cannabis in October 2018, becoming the first G7 country to do so. The results:

• Adult use increased slightly (from 14% to 17%), but youth use declined (from 20% to 10% among 15-17 year olds)
• Cannabis-impaired driving arrests increased initially but have since stabilised
• Tax revenue of CAD $4.3 billion (£2.5 billion) from 2018-2023
• The illegal market has shrunk from 80% of sales in 2018 to 20-30% in 2024
• No significant increase in cannabis use disorder or psychosis, though long-term data is still emerging

Germany (2024)

Germany legalised cannabis in April 2024, allowing adults to possess up to 25 grams and grow up to three plants at home. Cannabis social clubs (non-profit cooperatives) can grow and distribute to members. Commercial sales are planned for 2025.

It is too early to assess the impact, but the move has increased pressure on other European countries, including the UK, to reconsider their policies.

United States (24 states)

24 US states have legalised recreational cannabis, covering over 50% of the US population. The results vary by state, but overall:

• Youth use has not increased and in some states has declined
• Cannabis arrests have fallen by 90-95% in states that legalised
• Tax revenue of over $15 billion (£12 billion) from 2014-2023 across all legal states
• The illegal market persists in some states (e.g., California) due to high taxes and regulatory barriers, but has largely disappeared in others (e.g., Colorado, Oregon)

Netherlands (toleration since 1976)

The Netherlands has tolerated small-scale cannabis sales in licensed "coffeeshops" since 1976, though production remains illegal. The result is a grey market that has worked reasonably well for decades, with:

• Low youth use (5.4% of adults, lower than the UK)
• Separation of cannabis from harder drugs
• Tourism revenue from cannabis tourism (though this is controversial)

However, the Dutch model is inconsistent (sales are legal, production is not) and has led to problems with organised crime controlling production. The Netherlands is now experimenting with legal production in a pilot programme.

Portugal (decriminalisation since 2001)

Portugal decriminalised drug possession for personal use in 2001, treating it as a public health issue rather than a criminal matter. Cannabis remains illegal to sell, but possession of up to 25 grams is not a criminal offence.

The results have been overwhelmingly positive:

• Drug deaths fell by 80% from 2001 to 2020
• HIV transmission among drug users fell by 95%
• Drug use rates are among the lowest in Europe
• Treatment uptake increased as people were no longer afraid of criminalisation

Portugal's model shows that decriminalisation (even without legalisation) can reduce harm and improve public health.

The political obstacles

Despite growing public support and international evidence, legalisation faces significant political obstacles in the UK:

1. Government opposition

Both the Conservative and Labour parties officially oppose legalisation. The Labour government elected in 2024 has ruled it out, with Home Secretary Yvette Cooper stating: "We will not legalise cannabis. It is harmful, particularly to young people."

This position is driven by:

• Fear of tabloid backlash — the Daily Mail and other tabloids are strongly opposed to legalisation
• Concern about being seen as "soft on drugs" — a political liability, particularly for Labour
• Lack of political will — cannabis legalisation is not a priority for voters compared to the NHS, cost of living, or housing

2. Medical and police opposition

The Royal College of Psychiatrists and some police chiefs oppose legalisation, citing concerns about harm to young people and increased use.

However, this opposition is not unanimous. The Royal College of Physicians has called for an evidence-based review of cannabis policy, and several police chiefs have said that cannabis should be deprioritised in favour of tackling serious crime.

3. Lack of a clear model

There is no consensus on how to legalise. Should the UK follow the Canadian model (commercial sales), the Dutch model (toleration), or the Portuguese model (decriminalisation)? Should cannabis be sold in dedicated stores, pharmacies, or licensed premises? What tax rate should apply?

These questions are complex and require careful policy design. The lack of a clear, agreed model makes it easier for politicians to avoid the issue.

What happens next?

Despite the obstacles, momentum for reform is building:

• Public support has reached a majority (53%) and continues to grow, particularly among younger voters
• International evidence from Canada, Germany, and US states shows that legalisation can work
• Cross-party MPs are increasingly willing to speak out in favour of reform
• Economic pressures — the potential for £1 billion+ in tax revenue and criminal justice savings — make legalisation attractive in a time of fiscal constraint

The most likely path to legalisation is:

1. Continued pressure from campaigners, including Transform Drug Policy Foundation, CLEAR Cannabis Law Reform, and Volteface
2. A shift in Labour Party policy, possibly after the next election if younger, more liberal MPs gain influence
3. A pilot programme in a city or region (e.g., London, Manchester) to test a regulated market, similar to Germany's cannabis social clubs
4. Gradual rollout if the pilot is successful

Alternatively, the UK could follow the Portuguese model of decriminalisation without legalisation, treating possession as a public health issue rather than a criminal matter. This would be easier to implement politically and would address many of the harms of prohibition (criminalisation, racial disparities) without requiring a legal market.

The bottom line

Support for cannabis legalisation in the UK has reached 53%, with cross-party MPs, police chiefs, and medical professionals calling for evidence-based reform. Canada, Germany, and 24 US states have legalised recreational cannabis, generating billions in tax revenue and reducing criminal justice costs, with no significant increase in youth use. The UK cannabis market is worth £2.6 billion annually, entirely controlled by criminal gangs. Medical cannabis has been legal since 2018, but access remains severely restricted.

The case for legalisation is strong: it would reduce crime, generate tax revenue, improve public health through quality control and age restrictions, expand medical access, and address racial disparities in drug enforcement. The case against—that cannabis is harmful and legalisation would increase use—is not supported by international evidence, which shows that well-regulated legal markets can minimise harm.

The question is no longer if the UK will legalise cannabis, but when and how. The government remains opposed, but public opinion, international evidence, and economic pressures are building momentum for reform. The most likely path is a pilot programme followed by gradual rollout, or decriminalisation as an interim step. Either way, the era of cannabis prohibition in the UK is drawing to a close.